title: Reverse Genetics Approaches to Control Arenavirus.
abstract: Several arenavirus cause hemorrhagic fever disease in humans and pose a significant public health problem in their endemic regions. To date, no licensed vaccines are available to combat human arenavirus infections, and anti-arenaviral drug therapy is limited to an off-label use of ribavirin that is only partially effective. The development of arenavirus reverse genetics approaches provides investigators with a novel and powerful approach for the investigation of the arenavirus molecular and cell biology. The use of cell-based minigenome systems has allowed examining the cis- and trans-acting factors involved in arenavirus replication and transcription and the identification of novel anti-arenaviral drug targets without requiring the use of live forms of arenaviruses. Likewise, it is now feasible to rescue infectious arenaviruses entirely from cloned cDNAs containing predetermined mutations in their genomes to investigate virus-host interactions and mechanisms of pathogenesis, as well as to facilitate screens to identify anti-arenaviral drugs and development of novel live-attenuated arenavirus vaccines. Recently, reverse genetics have also allowed the generation of tri-segmented arenaviruses expressing foreign genes, facilitating virus detection and opening the possibility of implementing live-attenuated arenavirus-based vaccine vector approaches. Likewise, the development of single-cycle infectious, reporter-expressing, arenaviruses has provided a new experimental method to study some aspects of the biology of highly pathogenic arenaviruses without the requirement of high-security biocontainment required to study HF-causing arenaviruses. In this chapter we summarize the current knowledge on arenavirus reverse genetics and the implementation of plasmid-based reverse genetics techniques for the development of arenavirus vaccines and vaccine vectors.
authors.affiliation: Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY, 14642, USA. luis_martinez@urmc.rochester.edu.
authors.forename: Luis
authors.initials: L
authors.lastname: Martínez-Sobrido
authors.affiliation: Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
authors.forename: Benson Yee Hin
authors.initials: BY
authors.lastname: Cheng
authors.affiliation: Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, 92037, USA. juanct@scripps.edu.
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: de la Torre
mesh_terms: D000818:Animals; D001117:Arenaviridae Infections / Q000276:immunology / Q000517:prevention & control*; D018050:Arenavirus / Q000276:immunology*; D006801:Humans; D059386:Reverse Genetics / Q000379:methods*; D014765:Viral Vaccines / Q000235:genetics* / Q000276:immunology*
chemical_list: D014765:Viral Vaccines
keywords: Antiviral drugs; Arenavirus GP-expressing cells; Arenavirus rescue systems; Arenavirus reverse genetics; Minigenome assays; Recombinant arenavirus; Reporter genes; Reporter virus; Single-cycle infectious arenavirus; Tris-segmented arenavirus; Vaccines; Virus vectors